Pain Reliever Caplets Recalled for Improper Storage Temperature
Over-the-counter pain reliever caplet products from Family Dollar stores are being recalled because they were stored outside proper temperature conditions.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is a CGMP storage temperature deviation, which is precautionary in nature rather than indicating direct contamination or known harm.
Plain-English summary
Family Dollar Stores, LLC is recalling multiple over-the-counter pain reliever caplet products marketed under the "Ready in Case" and "Good Sense" brand names. These products were distributed nationwide between April 30, 2022 and June 10, 2022.
The products are being recalled because they were held outside the appropriate storage temperature conditions required by Current Good Manufacturing Practice (CGMP) standards. This storage deviation may affect product integrity.
Affected products include SKUs 902381, 902332, 913982, 999029, and 913890. Consumers who have purchased these products should stop using them.
The recalled product
- Product
- READY IN CASE PAIN RELIEVER PM CAPLET 100 CT SKU 902381 GOOD SENSE PAIN RELIEVER APAP 500MG CAPLET 250CT SKU 902332 READY IN CASE PM PAIN RELIEVER CAPLET 50 CT SKU 913982 GOOD SENSE PAIN RELIEVER APAP ES 500 CT SKU 999029 GOOD SENSE PAIN RELIEVER CAPLET 100 CT SKU 913890
- Manufacturer
- Family Dollar Stores, Llc.
- Hazard
- improper-storage-temperature
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- SKUs: 902381
- 902332
- 913982
- 999029
- 913890
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27